Sotera Health Company carries a market capitalization of 4.28B, placing it among publicly traded companies globally. Its enterprise value stands at 6.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.28B |
| Enterprise Value | 6.03B |
Sotera Health Company currently has 285.16M shares outstanding.
| Shares Outstanding | 285.16M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Sotera Health Company trades at a trailing price-to-earnings ratio of 34.61. The price-to-sales ratio is 3.43, and the price-to-book ratio stands at -8.11.
| PE Ratio | 34.61 |
| PS Ratio | 3.43 |
| PB Ratio | -8.11 |
| P/TBV Ratio | -5.40 |
| P/FCF Ratio | 9.67 |
| P/OCF Ratio | 15.61 |
On an enterprise value basis, Sotera Health Company trades at an EV/EBITDA multiple of 11.89 and an EV/FCF ratio of 11.80. The EV/Sales ratio of 5.07 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.84 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.07 |
| EV / EBITDA | 11.89 |
| EV / EBIT | 15.84 |
| EV / FCF | 11.80 |
Sotera Health Company maintains a current ratio of 2.82, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 364.70, indicating elevated leverage, while an interest coverage ratio of 3.39 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.82 |
| Quick Ratio | 2.36 |
| Debt / Equity | 364.70 |
| Debt / EBITDA | 4.47 |
| Interest Coverage | 3.39 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 3.72 |
| Return on Invested Capital (ROIC) | 7.72 |
| Return on Capital Employed (ROCE) | 11.67 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.98 |
Over the trailing twelve months, Sotera Health Company has paid 87.14M in income taxes, reflecting an effective tax rate of 42.52.
| Income Tax | 87.14M |
| Effective Tax Rate | 42.52 |
Sotera Health Company's stock has gained approximately 22.3127% over the past 52 weeks. The 50-day moving average sits at 15.27, while the 200-day moving average is 16.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | 22.3127% |
| 50-Day Moving Average | 15.27 |
| 200-Day Moving Average | 16.26 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sotera Health Company generated 1.19B in revenue and converted that into 117.80M in net income, yielding earnings per share of 0.41. EBITDA reached 507.53M, while operating income came in at 380.82M.
| Revenue | 1.19B |
| Gross Profit | 657.17M |
| Operating Income | 380.82M |
| Pretax Income | 204.94M |
| Net Income | 117.80M |
| EBITDA | 507.53M |
| EBIT | 380.82M |
| Earnings Per Share (EPS) | 0.41 |
Sotera Health Company holds 314.15M in cash and equivalents against 2.27B in total debt, resulting in a net debt position of 1.82B. Total book value stands at -502.64M, with working capital of 378.17M providing operational flexibility.
| Cash & Cash Equivalents | 314.15M |
| Total Debt | 2.27B |
| Net Debt | 1.82B |
| Equity (Book Value) | -502.64M |
| Book Value Per Share | -1.77 |
| Working Capital | 378.17M |
Sotera Health Company produced 261.11M in operating cash flow over the past twelve months. After subtracting -164.27M in capital expenditures, free cash flow totaled 96.84M - equivalent to 0.34 per share.
| Operating Cash Flow | 261.11M |
| Capital Expenditures | -164.27M |
| Free Cash Flow | 96.84M |
| FCF Per Share | 0.34 |
Sotera Health Company operates with a gross margin of 55.26, reflecting its pricing power and cost economics. The operating margin of 32.02 and net profit margin of 9.91 provide insight into operational efficiency.
| Gross Margin | 55.26 |
| Operating Margin | 32.02 |
| Pretax Margin | 17.23 |
| Profit Margin | 9.91 |
| EBITDA Margin | 42.68 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.58 |
| FCF Yield | 10.34 |
Sotera Health Company posts an Altman Z-Score of 2.12, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.12 |